Paragraph 2 Amendment of the Access to Medical Treatments (Innovation) Act 2016

In section 3(2)(b) and (4)(a), (b) and (c) of the Access to Medical Treatments (Innovation) Act 2016^f1 (provision supplementary to section 2: database of innovative treatments) insert “UK” before “marketing authorisation”.